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Abstract:  Aflatoxins  are  carcinogenic  secondary  metabolites  produced  by  the  fungi 
Aspergillus flavus and Aspergillus parasiticus. Previous studies found that repeated serial 
mycelial transfer or treatment of A. parasiticus with 5-azacytidine produced colonies with 
a fluffy phenotype and inability to produce aflatoxins. To understand how these treatments 
affect expression of genes involved in aflatoxin production and development, we carried 
out  expressed sequence tag (EST)-based microarray assays  to  identify  genes  in  treated 
clones that are differentially expressed compared to the wild-type. Expression of 183 genes 
was  significantly  dysregulated.  Of  these,  38  had  at  least  two-fold  or  lower  expression 
compared to the untreated control and only two had two-fold or higher expression. The 
most frequent change was downregulation of genes predicted to encode membrane-bound 
proteins.  Based on this  result we hypothesize that the treatments  cause changes  in  the 
structure  of  cellular  and  organelle  membranes  that  prevent  normal  development  and 
aflatoxin biosynthesis. 
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1. Introduction  
Formation  of  the  asexual  reproductive  structure  called  a  conidiophore  in  Aspergillus  species 
requires the concerted activity of a number of transcription factors and signaling proteins. Some of the 
transcription regulatory genes involved in this process are genes in the Velvet complex (veA, velB, 
vosA, and laeA; null mutants have a velvety appearance) and the so-called fluffy gene family (fluG and 
flbA-E;  null  mutants  have  a  floccose  or  fluffy  phenotype).  fluG  encodes  a  GSI-type  glutamine 
synthetase that is needed for production of a diffusible factor that provides the signal for initiation of 
conidiophore development. flbA encodes a transcription factor that regulates the response to FluG. 
These proteins modulate the master transcription factor for conidial development, BrlA, a zinc-binding 
protein  with  two  Cys2His2  domains  [1,2].  In  mutants  of  brlA,  spores  are  not  produced  and  the 
conidiphore  stalks  elongate  to  give  a  bristle  appearance.  Another  protein,  FadA  is  involved  in  
G  protein  signaling  and  its  inactivation  is  necessary  for  production  of  both  sterigmatocystin,  an 
aflatoxin precursor, and conidial development in A. nidulans [3]. Other genes involved in conidiophore 
development are stuA (stunted) and medA (medusa). These are required for proper spatial orientation 
of the conidophores.  
A number of studies have shown that conidiophore development and secondary metabolism are  
co-regulated [4–7]. In the absence of veA, aflatoxins (AFs), the highly toxic hydrophobic secondary 
metabolites produced by some Aspergillus species [8], are not produced. Null mutants of laeA also are 
unable to produce AFs and other secondary metabolites. LaeA is believed to act by loosening the 
chromatin conformation to allow transcription at secondary metabolite loci [9–13]. LaeA was shown to 
bind to VeA [9], a result providing molecular evidence that development and secondary metabolism 
are  co-regulated.  Furthermore,  transcription  factors  NsdC  and  NsdD,  previously  only  found  to  be 
required for sexual development [14,15], have now been shown to be necessary for asexual stalk 
formation and AF production as well. 
Production of aflatoxin requires the coordinated transcription of about 30 clustered genes [16]. Two 
of  these  genes,  aflR  and  aflS  (aflJ),  have  been  implicated  as  pathway-specific  transcriptional  
regulators  [17–19].  aflR  encodes  a sequence specific Cys6Zn2  DNA-binding protein,  AflR, that  is 
responsible for transcriptional activation of most, if not all, aflatoxin structural genes [20–23]. AflR 
activity may be regulated by LaeA [4,24]. Previous studies suggested that AflJ, a protein unique to 
fungi,  is  a  co-activator  of  AF  gene  transcription  and  binds  to  AflR  [18,25].  AflJ  possesses  three 
transmembrane binding helices and a microbodies C-terminal targeting signal and is presumed to be 
membrane-bound [19]. Recently, it has been shown that another level of regulation of AF formation 
involves  the  ability  of  A.  parasiticus  to  form  specialized  peroxisomal  vesicles  necessary  for  the 
enzymatic  processing  of  precursor  metabolites  after  the  production  of  the  polyketide  [26–29]. 
Coordination of aflatoxisome development with aflatoxin gene expression may be mediated by VeA 
and other factors.  Toxins 2011, 3 
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It was previously found that serial transfer of macerated mycelia, without allowing conidiation, 
produced highly stable A. parasiticus mutants (called sec minus strains) which had a fluffy phenotype, 
reduced  spore  pigmentation,  and  inability  to  produce  AFs  [7,30–32].  In  these  mutants,  although 
expression of aflJ and other AF biosynthesis genes was downregulated it was possible to detect the 
production of some AF biosynthetic enzymes, a result suggesting that translation is occurring normally 
in the mutants [32]. Mutants with a “fluffy” phenotype were previously described that resulted from 
treatment  of  fungi  with  the  cytidine  analog,  5-azacytidine  (5-AC)  [33,34].  The  5-AC-treatment 
affected  the  formation  of  the  conidiophore  as  well  as  conidial  pigmentation.  The  5-AC  treatment 
subsequently was determined to act upon a specific target locus termed fluF1, a locus that still has not 
been  molecularly  defined  [34].  Although  5-AC  is  best  known  as  an  inhibitor  of  DNA  cytosine 
methyltranferases in eukaryotes, in Aspergillus species, where DNA methylation is lacking [33,35] or 
extremely low [36], 5-AC is most likely acting as a mutagen. Incorporation of 5-AC into DNA has 
been shown to cause C to G transversions or C to T transition mutations [37]. 
To provide additional insight into the causes of the phenotypic changes and the loss of aflatoxin 
(AF) production in fluffy mutants obtained by treatment with either 5-AC or by serial transfer we 
profiled the expression of genes using A. flavus cDNA microarrays. We found that of the 38 genes 
significantly  downregulated  two-fold  or  more  compared  to  the  parental  strain,  many  were  genes 
predicted to encode either membrane-bound proteins or transcription factors involved in regulation of 
developmental  processes  and  suggest  that  these  changes  interfere  with  normal  conidiophore 
development and formation of the specific organelles (aflatoxisomes [26]) required for AF formation. 
2. Materials and Methods 
2.1. Fungal Strains 
A. parasiticus SRRC 143 (or SU-1); ATCC #  56775) was used as the wild-type strain. It had 
previously been used for numerous studies of aflatoxin biosynthesis and the entire AF gene cluster has 
been sequenced [16]. This strain consistently produces aflatoxins when grown on conducive media [38]. 
Non-aflatoxigenic A. parasiticus clones derived from SU-1 were prepared by serial mycelial transfer 
as previously described [31] or by 5-AC treatment (1 mM in A&M medium for 36 h) as described for  
A.  nidulans  [33].  Spores  were  generated  on  either  Difco  Potato-Dextrose  Agar  (PDA)  (American 
Scientific Products, Charlotte, NC, USA) or 5% V8 juice, 2% agar plates. 
2.2. Culture Conditions 
For wild-type A. parasiticus (WT), an A. parasiticus 5-AC mutant, and an A. parasiticus serial 
transfer mutant  (serial  transfer),  fresh conidia  were inoculated into 200 mL A&M  liquid  medium  
(10
5 spores/mL) and incubated at 29 ° C with constant shaking (150 rpm). Mycelia were collected from 
clones after 16 and 24 h. Under these conditions AF production was found after 16 h (Figure 1). A 
total of six replicates were performed for each condition, with each replicate consisting of a total of  
4 separate cultures. The four cultures were combined and 20 mL of the resultant supernatant was 
isolated  for  AF  determination.  The  combined  mycelia  was  flash  frozen  in  liquid  nitrogen  in  a  
pre-chilled mortar and pestle and ground to a fine powder before storage at −80 °C. Toxins 2011, 3 
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Figure 1. Microarray experimental design. A. parasiticus wild-type (WT) and clones from 
serial mycelial transfer (SerTrans), and 5-azacytidine-treated (5-AC) fungi were grown for 
16 and 24 h on PDA medium. The average amount of aflatoxin produced across all six 
replicates is indicated within the circles. RNA was isolated from the mycelia at each time 
point and cDNAs were labeled with Cy3 (solid end of arrow) or Cy5 (arrowhead) dyes 
prior to microarray assay (ppm = parts per million). 
0 ppm 0 ppm
0 ppm 0 ppm 21ppm
9 ppm
WT SerTrans 5-Ac
16 hours
24 hours
 
2.3. Aflatoxin Evaluation 
AF production for all samples was evaluated by TLC and HPLC as previously described [39]. For 
TLC, dried samples were suspended in 50 μL of chloroform and spotted on TLC silica plates (Baker) 
before  developing  in  EMW  (ethanol:  methanol:  water;  96:3:1).  Aflatoxin  standard  containing  a 
mixture of B1, B2, G1, and G2 (Sigma 46300-U) was run as an external control. AF quantification was 
by HPLC [40]. 
2.4. Microarray Analyses 
For microarray analyses, RNA was isolated from 100 mg ground mycelia by suspending in 1 mL of 
Puresol (Biorad). After treatment with RNase-free DNase I (Aurum Total RNA fatty and fibrous tissue 
kit, Biorad), the resulting RNA was converted to cDNA and labeled as previously described [41]. The 
EST microarrays used in this study were described previously [42–44]. A total of 5002 genes were 
arrayed at least 3 times each and 21 aflatoxin biosynthetic genes were represented separately from the 
EST sequences on the array. The experimental design for the microarray studies is shown in Figure 1. 
To minimize dye effects in separate experiments each probe was labeled with a different dye. This 
“dye-flip” procedure using independent microarray slides increased the reliability of the analysis and 
reduced dye effects. All recommendations of the minimum requirements for a microarray experiment 
(MIAME)  checklist  [45]  were  observed.  The  hybridized  slides  were  scanned  and  analyzed  for 
statistically significant different expression levels as previously described [44]. The microarray results 
have been deposited at the National Center for Biotechnology Information, NCBI (GEO Submissions 
GSE30756; tracking number 16103924). Toxins 2011, 3 
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2.5. Quantitative RT-PCR (qRT-PCR) 
Gene specific primers (Table 1) for six genes significantly dysregulated based on the microarray 
results were used for a two step PCR protocol to detect transcript levels. Briefly, 750 ng of total RNA 
was used as the template for first-strand cDNA synthesis using oligo (dT)20 primers (50 ° C for 50 min, 
cDNA synthesis System Kit (Invitrogen)) and after deactivation of the reverse transcriptase at 85 ° C 
for 5 min, qPCR was carried out on the cDNAs using 0.5 μM each of forward and reverse primer, 2 μL 
of Fast Start DNA Master SYBR Green I mix (Roche Diagnostics) and 1 μL of cDNA in 20-μL 
capillary tubes in a Light Cycler 2.0 instrument (Roche) with the following conditions: pre-incubation 
(10 min at 95 ° C), amplification and quantification (95°  for 10 s, annealing temperature for specific 
primer for 8 s, 72°  for 5 s), 45 cycles: melting curve (65–95°  with 0.1
 ° C/s heating rate). Based on the 
standard  curves  abundance  of  transcripts  for  each  gene  was  calculated  by  the  Light  Cycler  
software  4.0.  To  ensure  accuracy,  a  non-template  negative  control  was  run  for  each  primer  pair. 
Generated fragments were confirmed by size separation on a 1% agarose gel. For normalization, the A. 
flavus tubulin gene (AFLA_124520) was selected. Relative expression levels were calculated as the 
ratio of the CT for the target gene to that of the CT for tubulin (Roche Applied Science Technical Note  
No. LC13/2001). A total of three replicates were performed for each time point. Statistical analyses 
were performed as previously described [44]. 
Table 1. Primers used for qRT-PCR. 
NCBI or TIGR Number  Sequence (5' to 3')  Product size (bp) 
aflJ  TGACTCTCCTTTTGCCGAATGT  250 
  GGGAATGGCAACGGTGGGCG   
XM_001824706 
(TC9112) 
TATGAGCCCCAACGCAACAGACAG  268 
CGGGTACGGCTCATTAGAAGGAC   
XM_002372755 
(TC10739) 
GCCCCAGCTTACCAAACGAGA  336 
AGGGATGAGGGGGAATGAAGTG   
XM_002373878 
(TC10202) 
TGCGGGAAATAATACGACAGGAA  359 
AAAGTAGCGACCCGGGCAGTAGTG   
XM_002380627 
(TC11938) 
GACCGCATCGTGGCTTTTCTAC  334 
AAGCATCATTCGTCATTCGTTCTG   
XM_002374352 
(TC9364) 
CCCACCGAAGACCTGACCTACAT  322 
CTGCCATCTGCCAAACTCCATTA   
3. Results 
3.1. Loss of Aflatoxin Production after 5-Azacytosine Treatment and Serial Mycelial Transfer 
The  non-aflatoxigenic  clones obtained  after  treatment  with  either  5-AC  or  repeated  mycelial 
transfer  were  of  several  morphological  types;  many  had  a  “fluffy”  phenotype  as  previously  
described [30,33,46]. A total of 4 separate cultures were confirmed to have the same fluffy phenotype 
and loss of AF production for each of the treatments. These clones were used to prepare RNA for the 
microarray studies. The fluffy phenotype consisted of a dense, undifferentiated mass of aerial mycelia 
with only sparse conidia. While the A. parasiticus SU-1 wild-type cultures produced about 6.0 µg/mL Toxins 2011, 3 
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AFB1 and 2.8 µg/mL AFG1 after 16 h and 14.9 and 5.8 µg/mL after 24 h, the fluffy mutant clones 
produced no detectable AFs or AF precursor metabolites under these conditions. 
3.2. Microarray Transcription Profiles in 5-Azacytosine-Treated and Serial Transfer Isolated Colonies 
Compared to Wild-Type 
In the microarray analyses approximately 20% of the genes showed a detectable signal. Microarray 
analyses were performed on cultures grown for 16 and 24 h in A&M medium. The ratios of mRNAs 
from untreated and treated cultures grown for both amounts of time were similar and only the values 
for  the  16  h  cultures  are  listed  in  Tables  2  and  3.  Of  the  aflatoxin  cluster  genes  only  aflJ  was 
significantly downregulated more than 1.5-fold by either treatment. The microarray study detected  
194 EST features that showed significant differences in expression from the wild-type (p ≤ 0.002). 
These represent  about  163 unique genes.  Of these genes  only 35 were  downregulated 1.5-fold or 
greater in treated cultures compared to the wild-type cultures with a high probability cut-off of 0.0001 
or lower (Table 3). Most of the genes that met these criteria (Table 3) were downregulated with ratios 
of  wild-type  to  treated  culture  ranging  from  2-  to  10-fold.  Only  two  that  met  these  criteria  were 
upregulated.  Of  the  downregulated  genes  18  were  predicted  to  encode  proteins  with  membrane 
spanning domains typical of those in receptors involved in transport, nutrient acquisition, or signaling. 
Seven genes listed in Table 3 are predicted to encode transcription regulatory proteins; the remaining 
14  genes  fell  into  different  categories  including  7  predicted  to  have  catalytic  function.  The  most 
downregulated of the putative genes from treated clones were predicted to encode two different types 
of ankyrin-repeat domain proteins. Quantitative reverse-transcription (qRT) PCR was performed on 
mRNAs  encoded  by  six  genes  (marked  with  a  star  *  in  Tables  2  and  3).  Correlation  with  the 
microarray  results  was  0.80  or  higher.  The  genes  for  confirmation  were  chosen  based  on  their 
significant downregulation compared to the parental strain. Expression of genes known to be involved 
in transcriptional regulation of developmental and secondary metabolite synthesis such as veA, laeA, 
and nsdD (Table 4) was not significantly affected by the treatments. A second copy of a putative  
LaeA-encoding methyltransferase (laeA-2, AFLA_035950) was slightly more than 2-fold upregulated 
by both the 5-AC- and serial transfer treatments.  Toxins 2011, 3 
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Table  2.  Comparison  of  aflatoxin  cluster  gene  expression  in  treated  and  untreated  
A. parasiticus SU1 detected on microarray 
a.
 
Gene  Ratios
  Probabilities 
b 
  Untreated vs.  
5-AC-treated 
Untreated vs.  
5-AC-treated 
Untreated vs. 
Serial transfer 
Untreated vs. 
Serial transfer 
adhA  1.22  1.10  0.4388  0.3307 
aflJ 
*  1.76  1.59  0.0018  0.0015 
aflR  1.29  1.12  0.3367  0.3465 
aflT  1.32  1.11  0.3321  0.2423 
avfA  1.31  1.17  0.2902  0.4271 
avnA  1.25  1.18  0.3835  0.2162 
cypX  1.33  1.15  0.1235  0.0835 
estA  1.33  1.25  0.1929  0.0493 
hexA  1.37  1.12  0.0768  0.1850 
hypB1  1.24  0.95  0.2552  0.8827 
hypB2  2.49  2.16  0.4722  0.5134 
moxY  1.26  1.09  0.1828  0.1875 
nadA  1.24  1.07  0.4882  0.4211 
nor-1  1.41  1.12  0.0570  0.0620 
norA  1.33  1.07  0.0553  0.2726 
omtA  1.35  1.28  0.0422  0.0741 
omtB  1.37  1.08  0.0385  0.2716 
ordA  1.34  1.25  0.2363  0.1889 
ordB  1.35  1.31  0.1566  0.0602 
pksA  1.27  1.08  0.2264  0.1826 
sugR  1.32  1.10  0.3869  0.3722 
vbs  1.26  1.05  0.1547  0.1843 
ver-1  1.23  1.10  0.7285  0.9483 
verA  1.16  1.08  0.5312  0.8985 
verB  1.24  1.15  0.1683  0.1181 
a Genes  are  in  the  70  kb  aflatoxin  biosynthetic  cluster.  Their  functions  have  been  previously 
described [16]; 
b Probability determinations for microarray experiments were done as previously 
described [47]; * Differential expression was confirmed by qRT-PCR. Toxins 2011, 3 
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Table 3. Genes differentially expressed in wild-type and 5-azacytidine (5-AC)-treated and serial mycelial transfer clones 
a. 
TC Number or 
EST 
b 
Best Match 
GenBank 
c 
Putative Protein  Ratios 
d  Probabilities 
d 
         Untreated 
vs. 5-AC-
treated 
Untreated 
vs. Serial 
transfer 
Untreated 
vs. 5-AC-
treated 
Untreated 
vs. Serial 
transfer 
TC8344  XM_001824592  HET&ankyrin domain protein  10.02  8.53  0.0000  0.0000 
TC10739 *  XM_002372755  Ankyrin repeat-containing protein  5.69  4.52  0.0000  0.0000 
TC9364 *  XM_002374352  FG-GAP (integrin) repeat protein  4.79  3.97  0.0000  0.0000 
TC9256  XM_002375859  Nitrite reductase (NiiA)  4.58  3.38  0.0000  0.0000 
NAGAO52TV  XM_002380681  Polysaccharide synthase Cps1  4.54  4.72  0.0000  0.0000 
TC10370  XM_002384463  Opsin  4.18  3.49  0.0000  0.0000 
TC8557  XM_001827098  alpha1,3-glucan synthase  3.71  2.62  0.0000  0.0000 
TC10767 *  XM_003096248  Integral membrane protein  3.54  2.49  0.0000  0.0002 
TC10268  XM_002383371  12 kda heat shock protein  3.53  3.48  0.0000  0.0000 
TC9112 *  XM_001824706  GPI-anchored protein  3.45  3.00  0.0000  0.0000 
TC10523  XM_002374369  Integral membrane prot-exocytic transport from Golgi  3.40  3.53  0.0000  0.0000 
NAGCY20TV  XM_002379925  Gal4 transcription factor-AFLA_139560  3.28  3.20  0.0000  0.0000 
NAGAE41TV  XM_002382445  Calcium binding protein Caleosin  3.23  3.09  0.0000  0.0000 
TC10524  XM_002374369  Exocytic transport protein  3.21  3.28  0.0000  0.0000 
TC10334  XM_002379834  GABA-permease  3.11  2.69  0.0000  0.0000 
TC11140  XM_002383723  MFS-transporter-related  3.02  2.18  0.0000  0.0007 
TC11938 *  XM_002380627  EsdC  2.98  2.71  0.0000  0.0000 
NAFCO41TV  XM_001819214  Transcriptional regulatory protein pro1 (HLH protein)   2.88  2.35  0.0000  0.0000 
TC11262  XM_002384600  Helix-loop-helix DNA-binding domain protein   2.75  2.40  0.0000  0.0001 
TC10225  XM_003189329  SH3 domain kinase binding protein (predicted membrane protein)  2.70  2.47  0.0000  0.0000 
TC8802  XM_002378642  Ser-thr rich protein AOS28(solid-state culture specific gene)  2.66  2.63  0.0000  0.0000 
TC11294  XM_002384659  Arrestin domain protein  2.54  1.92  0.0000  0.0007 
TC8781  XM_002375350  MAPEG superfamily protein pfam01124  2.45  1.81  0.0000  0.0003 Toxins 2011, 3 
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Table 3. Cont. 
TC Number or 
EST 
b 
Best Match 
GenBank 
c 
Putative Protein  Ratios 
d  Probability 
d 
         Untreated 
vs. 5-AC-
treated 
Untreated 
vs. Serial 
transfer 
Untreated 
vs. 5-AC-
treated 
Untreated vs. 
Serial transfer 
TC10523  XM_002374369  Hypothetical protein  2.40  2.54  0.0000  0.0000 
TC10950  XM_002377280  RTA domain protein (RTA1 superfamily, pfam04479)   2.15  1.82  0.0000  0.0000 
TC8911  XM_002383317  Aspartic endopeptidase; aspartyl proteinase   2.13  1.82  0.0000  0.0002 
TC8680  XM_002382580  GPI-anchored glycoprotein (AFLA_004200)  2.03  1.98  0.0000  0.0000 
TC9120  XM_002381180  bZIP transcription factor ATFB (atf21, AFLA_094010)  2.02  1.96  0.0000  0.0000 
TC8511  XM_002383753  Hypothetical protein  1.92  2.11  0.0000  0.0000 
NAFBR39TV  XM_002378094  alpha/beta hydrolase domain protein  1.90  1.66  0.0000  0.0002 
TC9105  XM_001824752  Hypothetical protein  1.87  1.96  0.0000  0.0000 
TC10397  XM_002379378  PHD finger and SET domain protein  1.67  1.75  0.0000  0.0000 
TC9269  XM_002384586  Metallophophodiesterase (AFLA_119200)  1.66  1.55  0.0000  0.0001 
TC9718  XM_002372994  CVNH superfamily (cyanovirin-N family, pfam08881)  0.53  0.61  0.0000  0.0001 
NAFEY64TV  XM_002377133  Asparagine synthase (glutamine-hydrolyzing)  0.49  0.52  0.0001  0.0003 
a Only genes expressed at the 99.9% confidence level with ratio of 1.5-fold or higher or 0.5 or lower are shown. A star (*) indicates that the difference was confirmed by 
qRT-PCR; 
b  DNA  sequence  labels  correspond  to  expressed  sequence  tags  (EST)  or  tentative  consensus  sequences  (TC)  as  per  the  DFCI  A.  flavus  Gene  Index 
(http://weir.statgen.ncsu.edu/cgi-bin/gbrowse/aflavus_dec_2005/#search); 
c Matches to GenBank sequences were based on Blast of the EST sequence against the GenBank 
Nucleotide  collection  (http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&BLAST_PROGRAMS=megaBlast&PAGE_TYPE=BlastSearch&SHOW_DEFAULTS= 
on&BLAST_); 
d Ratios and probabilities are for data from the 16 h time point. Substantially similar data were obtained at 24 h. 
 Toxins 2011, 3 
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Table  4.  Comparison  of  expression  of  some  known  genes  involved  in  secondary 
metabolism, and fungal development. 
Gene  Ratios  Probabilities   Expressed 
Sequence 
Tag (EST) 
GenBank 
Accession 
Number 
AFLA # 
   Untreated 
vs. 5-AC-
treated 
Untreated 
vs. Serial 
transfer 
Untreated 
vs. 5-AC-
treated 
Untreated 
vs. Serial 
transfer 
        
laeA  0.75  0.77  0.8998  0.8874  Unknown  XM_002374798  033290 
laeA-1 
1  0.41  0.40  0.0002  0.0002  TC9243  XM_002375064  035950 
veA  0.76  0.68  0.0307  0.0041  TC11465  XM_002380164  066460 
nsdD  1.83  0.99  0.0145  0.9512  TC10891  XM_002376000  020210A 
1 Another gene encoding a LaeA-like protein (AFLA_121330) is found in the fungal genome but 
was not annotated on the EST microarray. 
4. Discussion 
The morphologically variant Aspergillus parasiticus strains obtained by either 5-AC treatment or 
serial mycelial transfer showed strikingly similar expression profiles to A. flavus clones created by a 
slightly different serial transfer method [44]. The most dysregulated genes in clones obtained by both 
serial mycelial transfer and 5-AC treated mutants are predicted to encode membrane-bound proteins 
which could act as receptors or transporters or be involved in signaling or signal transduction. Of 
these, the most dysregulated gene (XM_001824592) encodes a protein predicted to have both protein 
kinase, HET and ankyrin repeat domains [48]. Such proteins typically are involved in protein-protein 
interactions. An ankyrin repeat is a 33-aa motif in proteins consisting of two alpha helices separated by 
loops and present in proteins known to be involved in signaling, transcription initiation, cell cycle 
regulation, ion transport, and signal transduction [49]. Therefore dysregulation of expression of this 
type of protein could be expected to cause pleiotropic effects on cell morphology and development. 
The  putative  HET  functionality  is  found  in  proteins  that  mediate  heterokaryon  incompatibility 
reactions. Such functionality could play a role in mediating the activity of the FluG factor that induces 
conidial  development  and  secondary  metabolism  and  in  this  case,  may  be  critical  for  normal 
development and AF production. 
Another  gene  (XM_002384463)  significantly  downregulated  by  either  treatment  is  predicted  to 
encode opsin, a protein with transmembrane helices that may bind a photoreactive chromophore [50]. 
Opsins are bound to the lipid bilayer, and when involved in light signaling, undergo a light-induced 
conformational change necessary to activate a G protein signaling cascade. Also represented on the 
microarray as significantly downregulated is an FG-Gap repeat-containing protein. FG-GAP repeats 
are found in proteins near the N-terminus of integrin alpha chains, a region that has been shown to be 
important for ligand binding in membranes. Integrins act as receptors and can mediate attachments 
between cells or mediate interactions with the environment. They also play a role in cell signaling and 
define cellular shape, mobility, and regulate the cell cycle. Integrins can mediate outside-in as well as 
inside-out signaling [51]. Toxins 2011, 3  
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Another intriguing hit among the most dysregulated genes is one (XM_002382445) predicted to 
encode the calcium-binding protein, caleosin [52]. Caleosins contain calcium-binding domains and 
have an oleosin-like association with lipid bodies. Caleosins are present at relatively low levels in 
plants  and  are  mainly  bound  to  microsomal  membrane  fractions  at  the  early  stages  of  seed 
development. As the seeds mature, overall levels of caleosins increase dramatically and are associated 
almost exclusively with lipid storage bodies. A similar function for these proteins in fungi could be an 
association with the specialized peroxisomal structures necessary for biosynthesis of the hydrophobic 
aflatoxin intermediates (see below).  
Other genes predicted to encode membrane-bound proteins are XM_001824706 (a GPI-anchored 
protein),  XM_002374369  (a  protein  involved  in  exocytic  transport),  XM_002379834  (a  GABA 
permease), XM_002383723 (a MFS transporter) and XM_003189329 (an SH3 domain kinase binding 
protein).  All  of  these  proteins  could  affect  nutrient  transport  or  transmission  of  environmental  
signals  [53,54].  GPI  (glycosylphosphatidylinositol)-anchored  proteins  contain  a  signal  peptide  that 
directs them to the endoplasmic reticulum, after which, the hydrophobic C-terminus is removed and 
replaced by the GPI-anchor. The protein is subsequently transferred to the Golgi apparatus and finally 
to the extracellular space. Since the anchor is the sole means of attachment of such proteins to the 
membrane, cleavage of the group by phospholipases results in controlled release of the protein from 
the membrane. Such proteins could mediate exocytic transport of the hydrophobic aflatoxins or other 
intermediates within and outside the fungal cell [55]. Hypothetical roles of these proteins are consistent 
with the changes in development and secondary metabolism found in the mutants created by the serial 
transfer or 5-AC treatments. Their involvement in the developmental changes in clones selected by the 
treatments remains to be proven. Downregulation of expression of genes encoding membrane-bound 
proteins described above could explain the loss of normal development of asexual structures required 
for proper formation of conidia. How this developmental change affects AF production is not clear. 
Further work is needed to determine if deletions of some of these genes produce clones with the same 
phenotype obtained by serial mycelial transfer or treatment with 5-AC. It is possible that more than 
one  gene  alteration  is  necessary  for  creating  the  non-aflatoxigenic  mutants  profiled  in  our  study. 
Putative roles for the genes are shown schematically in Figure 2. 
Other significantly dysregulated genes listed in Table 3 are genes predicted to encode transcription 
control  proteins.  These  include  a  protein  involved  in  regulation  of  early  sexual  development 
(XM_002380627, EsdC), a Gal4-type transcription factor, AFLA_139560, a helix-loop-helix domain 
DNA-binding  protein  (XM_002384600),  an  ATF/CREB  family  bZIP-type  transcription  factor 
(XM_002381180) that may bind to the cAMP-responsive element (CRE) to stimulate CRE-dependent 
transcription [56], and a PHD finger and SET domain protein (XM_002379378) [57–59] that could 
bind to histone H3 tri-methylated on lysine-4 (H3K4me3) or H3 tri-methylated lysine-9 (H3K9me3). 
SET domain proteins are mediator proteins that activate or repress chromatin activity depending on the 
presence of other chromatin proteins. Dysregulation of the Gal4 transcription factor, AFLA_139560 is 
particularly intriguing because it is located on chromosome 3 quite close to the cyclopiazonic acid 
(CPA) and adjoining aflatoxin gene clusters.  
Since the serial transfer or 5-AC created mutants examined by our expression profiling studies 
showed almost normal expression of most AF biosynthetic genes (Table 2), it is possible that the lack 
of  aflatoxin  production  results  from  an  inability  to  form  the  proper  organelles  necessary  for  AF Toxins 2011, 3  
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biosynthesis.  Recent  work  showed  that  a  specialized  peroxisomal  vesicle  is  needed  for  proper 
positioning of the biosynthetic enzymes [26–29]. Such vesicles, termed aflatoxisomes, are specialized 
for AF biosynthesis and may allow the coordination of catalytic steps needed for the proper tethering 
and ultimately export of the developing hydrophobic AF metabolite. If such a structure is not able to 
be  formed  properly  in  the  mutant  cells,  the  biosynthetic  proteins  cannot  catalyze  the  conversions 
needed for AF formation. Loss of this structure due to downregulation of genes that are involved in 
membrane  function  and/or  conidiophore  development  is  consistent  with  the  fluffy  phenotype  and  
non-aflatoxigenicity common to both the 5-AC and serial mycelial transfer mutants. If this is true, a 
level of control of AF production beyond transcription and translation may exist that could provide a 
target for remediation of AF formation in susceptible crops.  
Figure 2.  Model to explain how the dysregulated genes in the microarray study might 
affect  aflatoxin  production  and  conidiophore  development.  Abbreviations:  HSPs,  heat 
shock  proteins;  PKs,  protein  kinases;  CSN,  COP9  signalosome  involved  in  protein 
degradation  or  prevention  from  degradation;  TF,  transcription  factor;  HLH-DBP,  
helix-loop-helix DNA-binding protein; TAFs, transcription-activating factors. 
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Expression  of  laeA  (AFLA_033290),  the  transcriptional  activator  of  secondary  metabolite 
biosynthesis and development-specific transcription activators, was not found to be affected in clones 
obtained  by  either  treatment.  However,  expression  of  a  gene  encoding  an  laeA  homolog 
(AFLA_035950) was significantly upregulated in clones obtained by both treatments. This protein is 
similar to an LaeA antagonist found in A. nidulans (LaeA-1) that, based on previous studies [60]  
(N. Keller, personal communication) may interfere with the activity of LaeA. If LaeA-1 interferes with 
LaeA’s ability to regulate aflatoxin cluster gene expression it must do so without significantly altering 
expression of most of the AF biosynthesis genes.  
5. Conclusions  
In A. parasiticus both 5-AC treatment and serial mycelial transfer lead to loss of AF production and 
abnormal  conidophore  development.  The  microarray  experiments  reveal  that  similar  genes  are 
dysregulated by the two treatments. Of the 35 most dysregulated genes, more than half are predicted to 
be  involved  in  membrane  functions  such  as  signaling,  transport  or  guiding  protein  interactions. 
Downregulation  of  these  types  of  genes  could  account  for  the  phenotypic  changes  in  the  mutant 
cultures. In our study, loss of the ability to produce aflatoxins by these mutants is not a result of 
transcription inhibition of aflatoxin biosynthesis genes or translation of the mRNA. We hypothesize 
that the most likely explanation for the non-aflatoxigenicity of the treated cultures is their inability to 
form  the  proper  vesicle  structure  for  coordinated  enzymatic  conversion  of  AF  precursors  to  
stable metabolites.  
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